BIONEXUS GENE LAB CORP
BGLC·090628306·US·Common Stock·Basic Materials - Specialty Chemicals
BGLC (BIONEXUS GENE LAB CORP) is held by 2 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($495), WELLS FARGO & COMPANY/MN ($2). Net institutional sentiment: Bullish.
2
Holders
Avg rating(1 Elite)
$497
Total Value
100% (2)
Fund Consensus
2 buying - 0 selling
No verdict yet — fewer than 2 funds hold BGLC.
13F: Insider & Congress:
Continue exploring
Other Basic Materials stocks held by institutions
LINLINDE PLC
370 holders · $170.4B
ECLECOLAB INC359 holders · $53.7B
NEMNEWMONT CORP352 holders · $76.5B
FCXFREEPORT MCMORAN INC351 holders · $65.3B
SHWSHERWIN WILLIAMS CO351 holders · $56.5B
CTVACORTEVA INC340 holders · $45.1B
APDAIR PRODUCTS AND CHEMICALS I337 holders · $53.9B
CRHCRH PLC325 holders · $51.8B
VMCVULCAN MATLS CO324 holders · $30.7B
DDDUPONT DE NEMOURS INC323 holders · $13.3B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer